Joshua R. Disbrow's Net Worth
$2.22 Million
Who is Joshua R. Disbrow?
Joshua R. Disbrow has an estimated net worth of $2.22 Million. This is based on reported shares across multiple companies, which include ZYNEX INC, AYTU BIOPHARMA, INC, and Ampio Pharmaceuticals, Inc..
SEC CIK
Joshua R. Disbrow's CIK is 0001566240
Past Insider Trading and Trends
2016 was Joshua R. Disbrow's most active year for acquiring shares with 10 total transactions. Joshua R. Disbrow's most active month to acquire stocks was the month of October. 2017 was Joshua R. Disbrow's most active year for disposing of shares, totalling 7 transactions. Joshua R. Disbrow's most active month to dispose stocks was the month of February. 2017 saw Joshua R. Disbrow paying a total of $390,625.05 for 2,224,167 shares, this is the most they've acquired in one year. In 2017 Joshua R. Disbrow cashed out on 2,907,500 shares for a total of $450,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZYNEX INC (ZYXI) Snapshot price: $11.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +82.16% | 10K |
—
|
—
| 22.17K |
Jun 15
| |||
Form 4
| +70.38% | 10K |
—
|
—
| 24.21K |
Jun 1
| |||
Form 4
| +72.72% | 10K |
—
|
—
| 23.75K |
Jul 16
| |||
Form 4
| +400.00% | 20K |
—
|
—
| 25K |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.54
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
| +24.31% | 14K |
$1.86 | $26,079.20 | 71.59K |
Jun 14
| |||
Form 4
| -6.49% | -80.00K |
—
|
—
| 1.15M |
Dec 20
| |||
Form 4
| +10.04% | 112.37K |
$0.22 | $25,047.50 | 1.23M |
Dec 19
| |||
Form 4/A
| +24.74% | 222K |
$0.24 | $52,614.00 | 1.12M |
Nov 18
| |||
Form 4
| +24.74% | 222K |
$0.24 | $52,614.00 | 1.12M |
Nov 18
| |||
Form 4
| +820.46% | 800K |
—
|
—
| 897.51K |
Apr 16
| |||
Form 4
| +85.71% | 450K |
—
|
—
| 975.05K |
Jun 8
| |||
Form 4
| +11.70% | 55K |
$0.89 | $48,824.00 | 525.05K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
| +1,814.81% | 445.5K |
—
|
—
| 470.05K |
Oct 24
| |||
Form 4
| +85.37% | 226.1K |
$0.45 | $101,747.25 | 490.95K |
Mar 6
| |||
Form 4
| +130.61% | 150K |
—
|
—
| 264.84K |
Nov 7
| |||
Form 4
| +264.47% | 1.67M |
$0.15 | $250,000.05 | 2.3M |
Mar 16 - Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| +42.35% | 187.5K |
$0.75 | $140,625.00 | 630.19K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +60.38% | 166.67K |
$1.50 | $249,999.00 | 442.69K |
Nov 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +23.42% | 52.37K |
—
|
—
| 276.03K |
Aug 2
| |||
Form 4
| +564.57% | 190K |
—
|
—
| 223.65K |
Jul 7
| |||
Form 4
| +162.50% | 250K |
$0.40 | $100,000.00 | 403.85K |
May 6
| |||
Form 4
|
∞
| 153.85K |
$0.65 | $99,999.90 | 153.85K |
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ampio Pharmaceuticals, Inc. (AMPE) Snapshot price: $1.91
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||